DePuy Synthes commits a high share of their business resources to research in robotic surgery, and the patents that investment generates have drawn formal challenge proceedings from competitors. Those challenges confirm that the market treats their IP as commercially significant. Their patents completed examination with few objections, reflecting inventions built on clear technical ground. That research commitment reflects a company treating robotic surgery as an active development priority.
